Twist Bioscience
TWST
Twist Bioscience (TWST) Fails to deliver data
Key failure to deliver metrics for Twist Bioscience :
- Last SEC data release: 2024-04-30
- Last 15 days FTD volume: $0 M
- Last 3 months FTD volume: $4.75 M
- Last year FTD volume: $7.97 M
Failures to deliver for Twist Bioscience (TWST) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Twist Bioscience (TWST) - since 2018
Volume in USD (price x number of shares), data since 2018Twist Bioscience (TWST) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $4.84 M | 4.06% |
| 2023 | $4.66 M | -82.33% |
| 2022 | $26.37 M | -77.77% |
| 2021 | $0.11 B | 134.98% |
| 2020 | $50.49 M | 882.72% |
| 2019 | $5.13 M | 45.26% |
| 2018 | $3.53 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Organovo ONVO | $3.34 M | $3.96 M | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | N/A | $0.27 B | 🇬🇧 UK |
 Novavax NVAX | $36.99 M | $0.31 B | 🇺🇸 USA |
 Novocure
NVCR | $0.78 M | $7.27 M | Jersey |